Scleroderma is a health condition that involves thickening of the skin and may also affect internal organs. It can be difficult to diagnose due to the similarity with other health conditions that have similar characteristic and requires differentiation from these.
Upon initial presentation, a consultation with the patient is necessary to establish the previous medical history, indicative symptoms and family history of the disease or other conditions.
This is important to understand the medical history of the individual to establish the risk that scleroderma may be involved. In particular, past treatments of radiotherapy can increase the risk of the condition. Additionally, there are some environmental triggers that may lead to the initiation of the symptoms, such as exposure to silicon, radiation and some solvents.
Although there are currently no specific genes that have been identified to play a causative role in the development of scleroderma, there appears to be a genetic link because the condition tends to run in families. For this reason, individuals with suspected scleroderma should be asked about any other family members that may have experienced similar symptoms.
The skin is the most common area of the body to be affected by scleroderma and is involved in all forms of the disease. Indicative signs of the condition include:
In some cases, the involvement of other organs in the body may result in symptoms specific to affected organs. This is known as systemic sclerosis and can lead to the following symptoms, according to which organs are involved.
There is no single test for scleroderma that is able to effectively determine the involvement of the condition. Most patients present with symmetric thickening of the skin, and many are also affected by Raynaud’s phenomenon.
A skin biopsy of an affected area can be taken and tested in a laboratory setting for signs of scleroderma. These tests are able to identify anti-topoisomerase antibodies (e.g. anti-scl70) that are associated with the diffuse systemic form of the disease or anti-centromere antibodies that are associated with the limited systemic form.
The diagnosis of scleroderma can sometimes be confused with several other health conditions, including: